NATH BIOGENES (INDIA)
Back to Cashflow Statement
|
NATH BIOGENES (INDIA) Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2013 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹11 Cr | ₹39 Cr | ₹34 Cr | ₹-25 Cr | ₹-0.81 Cr |
What is the latest Net Cash Inflow / Outflow ratio of NATH BIOGENES (INDIA) ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹11 Cr |
| Mar2024 | ₹39 Cr |
| Mar2023 | ₹34 Cr |
| Mar2022 | ₹-25 Cr |
| Mar2013 | ₹-0.81 Cr |
How is Net Cash Inflow / Outflow of NATH BIOGENES (INDIA) Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹11 Cr | -70.85 | |
| Mar2024 | ₹39 Cr | 16.56 | |
| Mar2023 | ₹34 Cr | Positive | |
| Mar2022 | ₹-25 Cr | Negative | |
| Mar2013 | ₹-0.81 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of NATH BIOGENES (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATH BIOGENES (INDIA) | ₹305.8 Cr | -6% | -6.5% | 1.8% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹10,732.0 Cr | -1.4% | 5.9% | -13% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,801.8 Cr | -5.6% | 0.7% | -31.1% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,226.0 Cr | -3.1% | 6.9% | 2.4% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹1,007.4 Cr | -1.6% | -4.3% | -25.2% | Stock Analytics | |
| INDO US BIOTECH | ₹210.7 Cr | -5.8% | -1.5% | -29.5% | Stock Analytics | |
NATH BIOGENES (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATH BIOGENES (INDIA) | -6% |
-6.5% |
1.8% |
| SENSEX | -3.1% |
-2.8% |
-6.1% |
You may also like the below Video Courses